114TH CONGRESS 

2D SESSION H. R. 3537 

AN ACT 

To amend the Controlled Substances Act to add certain 

synthetic substances to schedule I, and for other purposes. 

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled, 
2 

•HR 3537 EH

1 SECTION 1. SHORT TITLE. 

2 This Act may be cited as the ‘‘Dangerous Synthetic 

3 Drug Control Act of 2016’’. 

4 SEC. 2. TREATMENT OF CERTAIN DESIGNER DRUGS AS 

5 SCHEDULE I CONTROLLED SUBSTANCES. 

6 (a) CANNABIMIMETIC AGENTS.—Schedule I, as set 

7 forth in section 202(c) of the Controlled Substances Act 

8 (21 U.S.C. 812(c)), is amended in subsection (d)(2)(B)— 

9 (1) in clause (xiv) by striking ‘‘and’’ at the end; 

10 (2) in clause (xv) by striking the period and in11 serting a semicolon; and 

12 (3) by adding at the end the following: 

13 ‘‘(xvi) 2-(2-methylphenyl)-1-(1-pentyl-1H14 indol-3-yl)ethanone (JWH–251); 

15 ‘‘(xvii) (1-butyl-1H-indol-3-yl)(4- 

16 methylnaphthalen-1-yl)methanone (4′-methyl 

17 JWH–073); 

18 ‘‘(xviii) 2-(3-methoxyphenyl)-1-(1-pentyl19 1H-indol-3-yl)ethanone (JWH–302); 

20 ‘‘(xix) N-(adamantan-1-yl)-1-(5- 

21 fluoropentyl)-1H-indole-3-carboxamide (5F– 

22 APICA); 

23 ‘‘(xx) quinolin-8-yl 1-(5-fluoropentyl)-1H24 indole-3-carboxylate (5F–PB–22); 
3 

•HR 3537 EH

1 ‘‘(xxi) N-(1-amino-3-methyl-1-oxobutan-2- 

2 yl)-1-pentyl-1H-indazole-3-carboxamide (AB– 

3 PINACA); 

4 ‘‘(xxii) N-(naphthalen-1-yl)-1-pentyl-1H5 indole-3-carboxamide (MN–24); 

6 ‘‘(xxiii) (1-(5-fluoropentyl)-1H-indazol-3- 

7 yl)(naphthalen-1-yl)methanone (THJ–2201); 

8 ‘‘(xxiv) N-(1-amino-3,3-dimethyl-1- 

9 oxobutan-2-yl)-1-pentyl-1H-indazole-3- 

10 carboxamide (ADBICA); 

11 ‘‘(xxv) methyl 2-(1-(5-fluoropentyl)-1H-in12 dazole-3-carboxamido)-3-methylbutanoate (5F– 

13 AMB); and 

14 ‘‘(xxvi) methyl 2-(1-(cyclohexylmethyl)-1H15 indazole-3-carboxamido)-3-methylbutanoate 

16 (MA–CHMINACA).’’. 

17 (b) SYNTHETIC OPIOIDS.—Schedule I, as set forth in 

18 section 202(c) of the Controlled Substances Act (21 

19 U.S.C. 812(c)), is amended in subsection (a) by adding 

20 at the end the following: 

21 ‘‘(43) Butyryl fentanyl. 

22 ‘‘(44) beta-Hydroxythiofentanyl. 

23 ‘‘(45) Acetyl fentanyl.’’. 

24 (c) OTHER DRUGS.—Schedule I, as set forth in sec25 tion 202(c) of the Controlled Substances Act (21 U.S.C. 
4 

•HR 3537 EH

1 812(c)), is amended in subsection (c) by adding at the 

2 end the following: 

3 ‘‘(29) 1-(naphthalen-1-yl)-2-(pyrrolidin-1- 

4 yl)pentan-1-one (α-naphyrone). 

5 ‘‘(30) 1-(2,3-dihydrobenzofuran-5-yl)propan-2- 

6 amine (5–APDB). 

7 ‘‘(31) 1-(2,3-dihydrobenzofuran-6-yl)propan-2- 

8 amine (6–APDB). 

9 ‘‘(32) 6,7-dihydro-5H-indeno[5,6-d][1,3]dioxol10 6-amine (MDAI). 

11 ‘‘(33) 5-iodo-2,3-dihydro-1H-inden-2-amine (5– 

12 IAI). 

13 ‘‘(34) 1-(4-bromofuro[2,3-f]benzofuran-8- 

14 yl)propan-2-amine (bromo-dragonfly). 

15 ‘‘(35) 1-(4-chloro-2,5-dimethoxyphenyl)propan16 2-amine (DOC). 

17 ‘‘(36) 1-(4-ethoxy-2,5-dimethoxyphenyl)propan18 2-amine (MEM).’’. 

Passed the House of Representatives September 26, 

2016. 

Attest: 

Clerk. 

114TH CONGRESS 

2D SESSION H. R. 3537 

AN ACT 

To amend the Controlled Substances Act to add 

for other purposes. certain synthetic substances to schedule I, and